AU4938397A - Methods of elevating amounts of hyaluronan in the human body - Google Patents

Methods of elevating amounts of hyaluronan in the human body

Info

Publication number
AU4938397A
AU4938397A AU49383/97A AU4938397A AU4938397A AU 4938397 A AU4938397 A AU 4938397A AU 49383/97 A AU49383/97 A AU 49383/97A AU 4938397 A AU4938397 A AU 4938397A AU 4938397 A AU4938397 A AU 4938397A
Authority
AU
Australia
Prior art keywords
hyaluronan
elevating
amounts
methods
human body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49383/97A
Inventor
Stefan Gustafson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyal Pharmaceutical Corp
Original Assignee
Hyal Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2193940 external-priority patent/CA2193940A1/en
Priority claimed from CA 2194750 external-priority patent/CA2194750A1/en
Application filed by Hyal Pharmaceutical Corp filed Critical Hyal Pharmaceutical Corp
Publication of AU4938397A publication Critical patent/AU4938397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
AU49383/97A 1996-12-24 1997-11-12 Methods of elevating amounts of hyaluronan in the human body Abandoned AU4938397A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA 2193940 CA2193940A1 (en) 1996-12-24 1996-12-24 Methods of elevating amounts of hyaluronan in the human body
CA2193940 1996-12-24
CA 2194750 CA2194750A1 (en) 1997-01-09 1997-01-09 Methods of elevating amounts of hyaluronan in the human body
CA2194750 1997-01-09
PCT/CA1997/000847 WO1998027990A1 (en) 1996-12-24 1997-11-12 Methods of elevating amounts of hyaluronan in the human body

Publications (1)

Publication Number Publication Date
AU4938397A true AU4938397A (en) 1998-07-17

Family

ID=25678945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49383/97A Abandoned AU4938397A (en) 1996-12-24 1997-11-12 Methods of elevating amounts of hyaluronan in the human body

Country Status (2)

Country Link
AU (1) AU4938397A (en)
WO (1) WO1998027990A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127826A0 (en) * 1998-12-29 1999-10-28 Laster Gail Restenosis drug therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895106A (en) * 1970-04-15 1975-07-15 Morrison L M Novel CSA and CSC for use in man and mammals to inhibit atherosclerosis and the recurrence of cardiovascular incidents in atherosclerotic mammals
FR2584606A1 (en) * 1985-07-12 1987-01-16 Dropic USE OF POLY- AND OLIGOSACCHARIDES FOR THE PRODUCTION OF ACTIVE MEDICAMENTS IN THE PATHOLOGIES OF CONNECTIVE TISSUE
DE3634392A1 (en) * 1986-10-09 1988-04-14 Knoll Ag USE OF POLYSULFATED LOW MOLECULAR DEXTRANSULFATES
IT1251183B (en) * 1991-08-28 1995-05-04 Opocrin Spa HIGH DENSITY DERMATAN SULPHATE, EQUIPPED WITH HIGH THROMBOLITHIC ACTIVITY, AND PHARMACEUTICAL FORMS THAT CONTAIN IT.
FR2691066B1 (en) * 1992-05-15 1995-06-09 Sanofi Elf USE OF EXOGENOUS GLYCOSAMINOGLYCANS, THEIR ANALOGS AS WELL AS THEIR FRAGMENTS, FRACTIONS AND DERIVATIVES, FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF THROMBOPENIA.
JPH07179349A (en) * 1993-12-24 1995-07-18 Terumo Corp Acyl derivative of chondroitin sulfate

Also Published As

Publication number Publication date
WO1998027990A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
AU2390000A (en) Rheological treatment methods and related apheresis systems
EP0815838A3 (en) External skin treatment composition
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU3728197A (en) Human telomerase
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU5383998A (en) Biocompatible medical devices with polyurethane surface
AU3625295A (en) Low profile defibrillation catheter
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5383498A (en) Human chemokine beta-13
AU4131597A (en) Sulfated polysaccharides and uses thereof in medical treatment
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU2418499A (en) Org-5222 in the treatment of depression
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU5333298A (en) Compositions and methods for tumour therapy
AU2068295A (en) Skin treatment composition
MD798F1 (en) Method of the mamma cancer treatment
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU5471098A (en) Bone stimulating factor
AU1538395A (en) Body structure
AU4938397A (en) Methods of elevating amounts of hyaluronan in the human body
AU1772397A (en) Medical article
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer